tranylcypromine has been researched along with Skin Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adejola, N; Alani, RM; Anders, NM; Bradner, JE; Chung, HJ; Cole, PA; Das, J; Dinkova-Kostova, AT; Eroglu, A; Fairall, L; Gomez, AV; Gray, JJ; Hancock, WW; Hayward, D; Hu, Y; Jeliazkov, JR; Kalin, JH; Kim, E; Mai, A; Mattevi, A; Milano, C; Panova, I; Proby, CM; Prusevich, P; Roberts, HJ; Roberts, JM; Roy Burman, SS; Rudek, MA; Ryu, B; Schwabe, JWR; Song, Y; Valente, S; Wu, M | 1 |
1 other study(ies) available for tranylcypromine and Skin Neoplasms
| Article | Year |
|---|---|
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors.
Topics: Aged; Animals; Antineoplastic Agents; Benzamides; Cell Line, Tumor; Cell Proliferation; Co-Repressor Proteins; Drug Design; Drug Screening Assays, Antitumor; Female; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Male; Melanoma; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; Nerve Tissue Proteins; Oligonucleotide Array Sequence Analysis; Pyridines; Repressor Proteins; Skin Neoplasms; Tranylcypromine; Xenograft Model Antitumor Assays | 2018 |